Sold Out
Book Categories |
Topics in this issue include: Targeting IGF-1R; Tyrosine Kinase Inhibitors in Lung Cancer; Targeting mTOR; Targeting Hedgehog; Mitotic Inhibitors; Topoisomerase I Inhibitors; and New Strategies and Drugs Inhibiting Folate Pathways.
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionNew Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America
X
This Item is in Your InventoryNew Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America
X
You must be logged in to review the productsX
X
X
Add New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America, Topics in this issue include: Targeting IGF-1R; Tyrosine Kinase Inhibitors in Lung Cancer; Targeting mTOR; Targeting Hedgehog; Mitotic Inhibitors; Topoisomerase I Inhibitors; and New Strategies and Drugs Inhibiting Folate Pathways., New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America to the inventory that you are selling on WonderClubX
X
Add New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America, Topics in this issue include: Targeting IGF-1R; Tyrosine Kinase Inhibitors in Lung Cancer; Targeting mTOR; Targeting Hedgehog; Mitotic Inhibitors; Topoisomerase I Inhibitors; and New Strategies and Drugs Inhibiting Folate Pathways., New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America to your collection on WonderClub |